Read again. Does save lives by 60%. No reduction in recurrent non-fatal (do not die) decompensated heart failure events.
Suggests rexiemestrocel-L will work well in combination with medications that reduce these non-fatal events.
- Forums
- ASX - By Stock
- Ann: Mesoblast Phase 3 Chronic Heart Failure Results
Read again. Does save lives by 60%. No reduction in recurrent...
-
- There are more pages in this discussion • 982 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
$1.13 |
Change
0.020(1.81%) |
Mkt cap ! $1.250B |
Open | High | Low | Value | Volume |
$1.08 | $1.13 | $1.08 | $2.037M | 1.857M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
10 | 26013 | $1.13 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.13 | 83087 | 16 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 273 | 1.125 |
15 | 61470 | 1.120 |
13 | 113236 | 1.115 |
15 | 94920 | 1.110 |
7 | 140181 | 1.105 |
Price($) | Vol. | No. |
---|---|---|
1.130 | 80447 | 12 |
1.135 | 235668 | 10 |
1.140 | 176362 | 14 |
1.145 | 64488 | 6 |
1.150 | 128946 | 10 |
Last trade - 13.00pm 19/07/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |